Tracer library / [68Ga]Ga-oxine
[68Ga]Ga-oxine
Also written as [68Ga]Ga-oxine; [68Ga]oxine; [Ga-68]Ga-oxine; [Ga-68]oxine
- Radionuclide
- Ga-68 t½ 67.71 min
- Modality
- PET
- Production route
- —
- Stage
- Clinical research
- Syntheses indexed
- 0
What it is
- Compound class
- 8-Hydroxyquinoline (oxine) complex - cell/RBC labeling agent
- Target / mechanism
- —
- Clinical application
- PET/CT imaging of the spleen using gallium-oxine-labeled, heat-damaged red blood cells for differentiation of splenic from non-splenic tissue and diagnosis of splenic anomalies PMID 36766669
- Theranostic pair
- —
Published syntheses
No synthesis has been parsed for this agent yet.
Clinical literature
Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.
- PET/CT of the Spleen with Gallium-Oxine-Labeled, Heat-Damaged Red Blood Cells: Clinical Experience and Technical Aspects.2023 · Diagnostics (Basel) · Clinical study
Need this precursor?We can point you to suppliers for [68Ga]Ga-oxine, or handle the enquiry for you.
Get in touchQuality control Preliminary - inferred from compound class
- Ph. Eur. monograph
- not verified No Ph. Eur. check is recorded for this entry.
- USP monograph
- not verified No USP check is recorded for this entry.
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); radiometal tracer -> metal impurities (rule); Ga-68, generator production assumed (no synthesis data found) -> Ge-68 breakthrough (preliminary)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [68Ga]Ga-oxine.
Get in touchNotes
Added from reverse module search (stage 6); 2 article(s) with Ga-68. Stage set/updated at stage 39 from PMID 36766669: 'Ten patients underwent [68Ga]gallium-oxine-RBC-PET/CT for the classification of eleven unclear lesions (3 intra-, 8 extrapancreatic).'.